Pharmablue / Papers / Drugs Eligibility criteria for early access programs in France / The Early Access program List of requirements – updated

The Early Access program List of requirements – updated

The Early Access program List of requirements – updated

2 June 2025

Pharmablue

Pharmablue

Did you like this article? Share on social networks:

email linkedin twitter link
Exploitant for Innovative Pharma Companies

Associated News

Ultimate Guide for European Early & Expanded Access Programs

Expanded Access is a treatment option that allows the use of an unauthorized medicine (investigational...

Learn more
How to take advantage of early access programs for your innovative treatments in France?

Known as Expanded Access Programs in the US, early access programs (EAP) allow access to...

Learn more
Benefits of using a third party Exploitant to run early access programs in France and more

Main benefits of outsourcing "Exploitant" status : Reminder : French regulatory authorities require having an...

Learn more